Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zantrex-3 ephedra alternative

This article was originally published in The Tan Sheet

Executive Summary

Ephedra-free, "super-stimulant" weight-loss supplement delivers "more than five times the weight loss" of Cytodyne's ephedra-containing Xenadrine RFA-1, Zoller Labs states in April 5 release. Salt Lake City-based Basic Research affiliate began selling Zantrex-3 in February at health food outlets including GNC and online. Labeling claims include "rapid weight loss" and "extreme energy," focus on supplement's superiority to ephedra. Zantrex-3 features proprietary blend including caffeine, guarana, kola nut and green tea; an 84-count bottle retails for $42.99...

You may also be interested in...

Zoller Labs Seeks To Bar Zantrex-3 Comparisons By NBTY

Zoller Labs requests an injunction prohibiting NBTY from certain statements comparing its Nature's Bounty Xtreme Lean ZN-3 weight-loss product to Zoller's Zantrex-3 in a lawsuit filed June 27 in Salt Lake City, Utah federal court

QUOTED. 21 January 2021. Larry Biegelsen.

The recently US FDA-cleared Velys robotic-assisted system from DePuy Synthes has distinct features. It also has a small footprint that makes it well-suited for ambulatory surgery centers. See what Larry Biegelsen, an analyst with Wells Fargo, said about it here.

Biden Regulatory Freeze Could Slam Brakes On SUNSET Reg Review Rule From HHS

The tactic aims to allow the new Biden administration to scrutinize so-called “midnight rules” issued in the final days of the Trump administration before they take effect. One reg targeted by the freeze is the recent SUNSET rule from the HHS, which would require the department and its agencies – including the FDA – to review all regulations every 10 years to determine whether they’re still necessary.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts